Status: Current Project
Location: Pakistan
Division: At-Risk Mental State (ARMS),
Schizophrenia Spectrum and Other Psychosis Disorder
Themes:
- Psychological Medicine & Clinical Trials
- Severe Mental Illness Including Psychosis
- Implementation Science & Health Systems
- Health Economics & Financing
Summary: A large, multi-centre, 3-arm RCT in Pakistan (390 participants) evaluating the clinical and cost-effectiveness of culturally adapted CBT (CaCBT) and family intervention (CulFI) vs. TAU for first-episode psychosis.
Description: The Problem: There is a critical need for robust evidence comparing the effectiveness and cost-effectiveness of different culturally adapted psychosocial interventions (‘talking therapies’) for people experiencing first-episode psychosis (FEP) in low-resource settings like Pakistan.
The Intervention: CaPSI is a large, multi-center, three-arm randomized controlled trial (RCT) involving 390 participants with FEP recruited from multiple clinical centres across Pakistan. Participants are randomized to receive either: 1) Culturally adapted CBT (CaCBT), 2) Culturally adapted Family Intervention (CulFI), or 3) Treatment as usual (TAU).
Objectives & Outcomes: The primary objective is to assess the reduction in overall psychotic symptomatology. Secondary aims evaluate improvements in patient outcomes (positive/negative symptoms, depression, cognition, insight, quality of life) and carer outcomes (experience, wellbeing, illness perceptions, anxiety/depression).
Our Impact: This trial will provide robust, head-to-head evidence on the clinical efficacy and cost-effectiveness of these culturally tailored interventions for FEP in a low-resource context. The findings have the potential to directly inform policy and practice, supporting the scalable implementation of effective psychosocial care across South Asia and other LMICs, ultimately improving outcomes for individuals with early psychosis.